logo
Doctors Say This Easy Habit Can Protect Your Brain As You Age—And Might Prevent Alzheimer's Disease

Doctors Say This Easy Habit Can Protect Your Brain As You Age—And Might Prevent Alzheimer's Disease

Yahoo17-05-2025

New research suggests being curious can protect brain health as you age.
Older adults who stay curious and learn new things may be able to offset Alzheimer's disease.
By tapping into your senses, you can easily experience newness in a known environment.
Little kids ask questions about absolutely everything: why you have to flush the toilet, what the backstory is for a stranger's tattoo, what love means. The list goes on and nothing is off-limits. But that curiosity tends to drop off as we grow up and get older. And apparently, recent research says that's not a good thing for your brain.
A new study suggests that older adults who maintain a healthy dose of curiosity and try to learn new things may be able to help offset or even prevent Alzheimer's disease. And yes, that almost sounds too easy to be true.
So, what's behind this curiosity-dementia link? Women's Health tapped neurologists for more.
Meet the experts: Clifford Segil, DO, is a neurologist at Providence Saint John's Health Center in Santa Monica, CA; Amit Sachdev, MD, MS, is the medical director in the Department of Neurology at Michigan State University
The study, which was published in PLOS One, recruited more than 1,200 people between the ages of 20 and 84, and asked them to fill out an online questionnaire with the goal of figuring out how curious they were in general.
The researchers then asked participants to guess the answers to hard trivia questions that most people likely wouldn't know. For example, What was the first country to give women the right to vote? (Answer: New Zealand!) After they guessed the answer, participants were asked how interested they were to know the answer before they were shown it.
The researchers discovered that people who have more "state curiosity" (which is a fleeting desire to know something) also have more "trait curiosity" (i.e. they're naturally curious), and vice versa. But the researchers also discovered that the drive to learn new things dropped in early adulthood, increased sharply after middle age, and continued upward into older age.
The researchers said in a press release that older adults who are able to stay curious and want to learn new things may be able to offset or even prevent Alzheimer's disease (even though the study didn't explicitly look at data to support this conclusion). But those who aren't interested in learning new things may be at risk for dementia.
This conclusion isn't groundbreaking, by the way: Other studies suggest that older adults who are highly curious have better long-term memory retention than their less-curious counterparts.
There are a few things going on that make your curiosity protective to your brain health. 'New interests develop robust connections in the brain,' says Amit Sachdev, MD, MS, medical director in the Department of Neurology at Michigan State University. 'This network of connections is what builds a more resilient brain.'
Doing the same thing repeatedly also gets old, points out Clifford Segil, DO, a neurologist at Providence Saint John's Health Center in Santa Monica, CA. 'As we age, trying to avoid this repetition is healthy,' he says. 'Reading a new book is likely better for your brain than reading an old book again.'
Ultimately, Dr. Segil says that seeking out new things 'may create new brain pathways rather than strengthening old pathways.'
Dr. Segil recommends that you try to touch on your five senses (vision, hearing, touch, smell, and taste) while experiencing new things.
That means eating new foods, looking at new art, and going to a concert and hearing something different, he says.
A lot of the scientific findings on this topic have similar conclusions when it comes to supporting good brain health:
Don't smoke.
Do moderate to vigorous exercise for at least 150 minutes a week.
Limit how much alcohol you have.
Try to do brain-stimulating activities, like reading, playing games, and visiting museums, regularly.
Eat a healthy, varied diet, like the MIND diet.
Oh, and of course, stay curious. You never know where it can lead you—and your mind.
You Might Also Like
Jennifer Garner Swears By This Retinol Eye Cream
These New Kicks Will Help You Smash Your Cross-Training Goals

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Rates of dementia are lower in people who eat this specific diet, research shows
Rates of dementia are lower in people who eat this specific diet, research shows

Yahoo

time2 hours ago

  • Yahoo

Rates of dementia are lower in people who eat this specific diet, research shows

Certain foods may feed the brain better than others. New research presented this week at NUTRITION 2025, the annual meeting of the American Society for Nutrition in Orlando, Florida, found that the MIND diet is particularly beneficial for cognitive health. People who followed the MIND eating plan — which stands for Mediterranean-DASH Intervention for Neurodegenerative Delay — were "significantly less likely" to develop Alzheimer's disease or other forms of dementia, according to a press release from the American Society for Nutrition. Brain And Memory Are Boosted By Eating One Particular Diet, Study Finds MIND is a hybrid of the Mediterranean diet and the DASH diet (Dietary Approaches to Stop Hypertension), the latter of which is designed to reduce blood pressure. The diet focuses on "brain-healthy foods" like leafy green vegetables, berries, nuts and olive oil. Read On The Fox News App "The MIND diet is unique as the first eating plan focused on foods to specifically improve and support cognitive health," Lauren Harris-Pincus, registered dietitian nutritionist and founder of and author of "The Everything Easy Pre-Diabetes Cookbook," told Fox News Digital. The plant-focused MIND diet highlights 10 types of food, including berries, leafy greens, veggies, whole grains, nuts and seeds, beans, legumes, seafood, poultry and olive oil, according to Harris-Pincus, who was not involved in the research. Red Meat Could Raise Dementia Risk, Researchers Claim, Yet Some Doctors Have Questions "These focus foods contain nutrients that play a critical role in supporting brain health, including flavonoids, carotenoids, B vitamins, omega-3 fatty acids (especially DHA), choline, and minerals like magnesium, potassium and calcium," she said. "The diet also suggests limiting foods such as pastries, refined sugar, red meat, cheese, fried foods, fast food, and butter or margarine." Researchers from the University of Hawaii analyzed data from nearly 93,000 U.S. adults who reported their dietary habits during the 1990s as part of the Multiethnic Cohort Study. At the start of the study, participants ranged in age from 45 to 75. In analyzing which participants developed Alzheimer's or other dementias in later years, the MIND eating plan performed better than other healthy diets in terms of reducing dementia risk, with benefits seen among both younger and older groups. Click Here To Sign Up For Our Health Newsletter Those who followed the diet were shown to have an overall 9% reduced risk of dementia, and some groups — African American, Latino and White participants — showed a 13% lower risk. Asian-Americans and native Hawaiians did not show as pronounced of a risk reduction. The longer people adhered to the diet, the greater the reduction of risk. Those who followed the plan over a 10-year period had a 25% lower risk compared to those who didn't stick with it. "Our study findings confirm that healthy dietary patterns in mid to late life and their improvement over time may prevent Alzheimer's and related dementias," said Song-Yi Park, PhD, associate professor at the University of Hawaii at Manoa, in the release. For more Health articles, visit "This suggests that it is never too late to adopt a healthy diet to prevent dementia."Original article source: Rates of dementia are lower in people who eat this specific diet, research shows

HUNDREDS OF HEALTH PROFESSIONALS, ATTORNEYS, ENVIRONMENTALISTS AND PATIENTS SET TO CONVENE AT THE ANNUAL CIRSx CONFERENCE 2025 TO ADDRESS MOLD ILLNESS, WHICH AFFECTS MILLIONS OF AMERICANS
HUNDREDS OF HEALTH PROFESSIONALS, ATTORNEYS, ENVIRONMENTALISTS AND PATIENTS SET TO CONVENE AT THE ANNUAL CIRSx CONFERENCE 2025 TO ADDRESS MOLD ILLNESS, WHICH AFFECTS MILLIONS OF AMERICANS

Yahoo

time6 hours ago

  • Yahoo

HUNDREDS OF HEALTH PROFESSIONALS, ATTORNEYS, ENVIRONMENTALISTS AND PATIENTS SET TO CONVENE AT THE ANNUAL CIRSx CONFERENCE 2025 TO ADDRESS MOLD ILLNESS, WHICH AFFECTS MILLIONS OF AMERICANS

LOS ANGELES, June 3, 2025 /PRNewswire/ -- The organizers of the Surviving Mold-CIRSx Conference 2025 is happy to announce Dr. Dale Bredesen as its keynote speaker, set to be held on June 6-8, 2025 at the Omni Tempe, located on the campus of Arizonia State University. He is an internationally-recognized expert in neurodegenerative diseases like Alzheimer's. He believes that the disease is not only preventable but reversible! He will address the topic of "A Unifying Theory of Neurodegeneration: The Roles of Environmental Exposure," discussing a direct link to mold exposure and Alzheimer's disease. More of his research on this topic can be found in his New York Times Best Seller, "The End of Alzheimer's." The international conference will bring together hundreds of health professionals, lawyers and legal experts, environmentalists, patients and survivors to discuss the latest science and research related to Chronic Inflammatory Response Syndrome (CIRS) – that is, mold illness and exposure -- which debilitates the health of millions each year. CIRS is a multisystem illness affecting many areas of the body. Every year, mold exposure affects the health of millions of Americans – kids, teens and adults -- with symptoms that include chronic fatigue and pain, watery eyes, headaches, respiratory issues, brain fog, irritability and sleep problems – just to name a few. Oftentimes, these symptoms can often lead to patients being misdiagnosed for other disorders like lupus, rheumatoid arthritis, Sjogren's syndrome, chronic fatigue syndrome, IBS, fibromyalgia, multiple sclerosis (MS), chronic regional pain syndrome and many other illnesses. "The Surviving Mold-CIRSx Conference brings together some of the world's top experts who will be teaching and presenting from the basic sciences to the most cutting-edge mold discoveries. This conference is the best place to meet practitioners in diverse fields and join the CIRS family," said Dr. McMahon, one of the co-founders of CIRSx, which hosts the annual conference. A pediatrician and medical expert, specializing in the field of CIRS in kids and adults, Dr. McMahon is considered one of the top CIRS specialists in the world. Throughout his career, he's evaluated approximately 2,000 patients for CIRS from 48 states and 21 countries. And he's been involved in more than 100 disability, workers compensation and personal injury cases, testifying in 10 states as well as Canada, England and the Bahamas. Dr. McMahon was recently tapped at the medical director of MoldCo, the first digital health platform dedicated to treating mold toxicity. During the conference, Dr. McMahon will speak on the topic, "Using Data to Restore Truth in the Courtroom," Plus, Dr. McMahon's mentor, Dr. Ritchie Shoemaker, THE pioneer and global expert on CIRS, will discuss a topic, which hits close to home – that is, "Brain Injury in CIRS: From Specific Causation to a Unique Transcriptomic Fingerprint in Parkinson's Disease." In addition, the conference will also offer 18.75 of Continuing Medical Education (CME) to its attendees. This conference has been approved by My CE Course for 18.75 hours credit in Category 1 of the Physician's Recognition Award of the American Medical Association. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the My CE Course (MyCE) through the joint providership of MyCE and The Learning Center. MyCE is accredited to provide continuing medical education for physicians, physician assistants and nurses. Other highlights of the conference include ED Talks, presented by its sponsors Air Oasis®, MoldCo and Alovéa. These brands will delve into the critical role it plays in the CIRS community in shaping consumer perception, establishing consumer confidence and driving business success. These talks will take attendees behind each of the brands' logo and tagline to share its mission, values and unique story of the company. Ariana Thacker, founder and CEO of MoldCo, will share her own journey in battling mold toxicity. For more information about the conference, visit ABOUT CIRSx, hosts of the Surviving Mold-CIRSx Conference is the leading resource in treating, educating and serving those with Chronic Inflammatory Response Syndrome (CIRS). Every year, hundreds of health professionals, lawyers and legal experts, environmentalists, patients and CIRS survivors gather at an annual conference, hosted by CIRSx to discuss the latest science and research on CIRS and other inflammatory illnesses. At the forefront of health innovation, CIRSx is dedicated to creating and refining standards that stay on the cutting edge of treating CIRS, using an evidence-based approach. Its mission is to transform multiple industries, revolutionizing their approaches toward CIRS and other environmentally-related health challenges. The heart of CIRSx is the compassionate healers and dedicated helpers. These professionals are not just experts in their field, but are also deeply committed to providing personalized care and support to those affected by CIRS. For more information about the conference, visit ABOUT SCOTT MCMAHON | pediatrician, medical expert and co-founder of CIRSxDr. McMahon is one of the leading voices on advancing the science to treat, educate and serve those suffering with CIRS. He received his medical degree from Creighton University and completed his pediatric residency at Duke University Medical Center. He has published over a dozen peer-reviewed papers on mold illness and is a recognized expert witness in mold-related court cases across the United States, Canada, Europe and the Bahamas. Dr. McMahon is also the host of MEDICINE AND MIRACLES, which integrates medical expertise with spiritual healing and offers a unique look at health and recovery through a faith-based perspective. MEDICINE AND MIRACLES can be found on digital platforms, including Spotify, Audible, iHeart Radio and Amazon Podcast. Learn more at He resides in Roswell, New Mexico, with his wife Mary and a blended family of eight children. View original content to download multimedia: SOURCE Dr. Scott McMahon of Whole World Health Care Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Bioxytran's Groundbreaking Stroke & Alzheimer's Tech Gains Validation That Measures Oxygenation Uptake During Strokes
Bioxytran's Groundbreaking Stroke & Alzheimer's Tech Gains Validation That Measures Oxygenation Uptake During Strokes

Associated Press

time11 hours ago

  • Associated Press

Bioxytran's Groundbreaking Stroke & Alzheimer's Tech Gains Validation That Measures Oxygenation Uptake During Strokes

Mongolian Gerbil Research Unlocks Critical Insights for Ischemic Stroke and Neurodegenerative Disease Treatments BOSTON, MASSACHUSETTS, June 03, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the 'Company'), a clinical stage biotechnology company developing drugs to treat stroke and Alzheimer's disease, announced that Bioxtran's Science Advisor Prof. Avraham Mayevsky's book titled The Mongolian Gerbil Brain: Mitochondrial Function, Vasculature, and Pathophysiological States was published by a publishing house, Springer. It is available by eBook or Hardcover. The publication serves as a scientific cornerstone for Bioxytran's clinical development program of the universal oxygen carrier (UOC) in ischemic stroke and Alzheimer's disease, and is directly tied to the use of the MDX Viewer as an analytical method to detect a brain regions response to the addition of a UOC. The device has FDA approval to measure tissue oxygenation. Bioxytran is pioneering a transformative approach to treating ischemic stroke and neurodegenerative disease. The UOC is capable of replacing hyperbaric oxygen treatment (HBOT) by efficiently delivering therapeutic type of oxygen at the cellular level versus a charged version of oxygen prevalent in HBOT treatment called reactive oxygen species (ROS). This breakthrough is powered by the MDX viewer that provides real-time metabolic insights – a crucial element of Bioxytran's regulatory approach. The Mongolian gerbil brain is special in that it lacks the vasculature compensatory mechanisms that can deal with decreased blood flow in the event of a stroke. Since the blood vessels in the Mongolian gerbil brain have no coping mechanism it makes them ideal in studying stroke pathophysiology. The research compiled in this publication further validates Bioxytran's scientific and clinical approach, positioning the company on the cutting edge of advancements in brain health and neuroprotective treatments. 'This research is paving the way for substantial advances in the understanding of the pathology of stroke and other neurodegenerative diseases, said Avraham Mayevsky, Member of Bioxytran's Medical Advisory Board. 'One of the biggest challenges in in clinical trials is determining the efficacy of a drug. This gerbil brain model has great predictive value in ischemic stroke and Alzheimer's disease. The gerbil model coupled with the MDX Viewer will provide us amazing insight in the pathogenesis of stroke and neurodegenerative diseases. Over 60 years went toward the development of the book which highlights a model of how brain anomalies are detected using this device.' About Bioxytran, Inc. Bioxytran, Inc. is at the forefront of developing complex carbohydrate-based therapeutics to address critical unmet medical needs in its three core platform technologies. These include virology, cancer metastasis, and oxygen transport. In addition to ProLectin-M, Bioxytran is advancing programs for pulmonary fibrosis and stroke treatment. When utilized by paramedics at the time of diagnosis BXT-25 has the possibility of reducing what is known as the time until needle by over 90%. For more information, visit Investor Relations Michael Sheikh 509-991-0245 [email protected] Forward-Looking Statements This press release includes forward-looking statements as defined under federal law, including those related to the performance of technology described in this press release. These forward-looking statements are generally identified by the words 'believe,' 'expect,' 'anticipate,' 'estimate,' 'intend,' 'plan,' and similar expressions, although not all forward-looking statements contain these identifying words. Such statements are subject to significant risks, assumptions and uncertainties. Known material factors that could cause Bioxytran's actual results to differ materially from the results contemplated by such forward-looking statements are described in the forward-looking statements and risk factors in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and those risk factors set forth from time-to-time in other filings with the Securities and Exchange Commission. Bioxytran undertakes no obligation to correct or update any forward-looking statement, whether as a result of new information, future events, or otherwise, except to the extent required under federal securities laws.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store